Farallon Capital Management’s Roivant Sciences ROIV Stock Holding History

Farallon Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$268M	Buy	9,675,000 +9,638,000	+26,049%	+$248M	1.53%	23
2025 Q4	$803K	Hold	37,000	–	–	﹤0.01%	88
2025 Q3	$560K	Hold	37,000	–	–	﹤0.01%	88
2025 Q2	$417K	Hold	37,000	–	–	﹤0.01%	95
2025 Q1	$373K	Hold	37,000	–	–	﹤0.01%	100
2024 Q4	$438K	Hold	37,000	–	–	﹤0.01%	101
2024 Q3	$427K	Sell	37,000 -636,000	-95%	-$7.24M	﹤0.01%	110
2024 Q2	$7.11M	Sell	673,000 -225,600	-25%	-$2.47M	0.03%	87
2024 Q1	$9.47M	Sell	898,600 -6,437,400	-88%	-$69.4M	0.04%	93
2023 Q4	$82.4M	Buy	7,336,000 +3,482,600	+90%	+$33.9M	0.38%	50
2023 Q3	$45M	Buy	3,853,400 +1,498,400	+64%	+$16.9M	0.21%	60
2023 Q2	$23.7M	Buy	+2,355,000	New	+$21.1M	0.12%	76

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Farallon Capital Management's ROIV Position: Q1 2026 in Review

Farallon Capital Management increased its Roivant Sciences (ROIV) stake by 26,049% in Q1 2026, buying an estimated $248M and bringing the position to 9,675,000 shares worth $268M. The position accounts for 1.53% of the portfolio, ranked #23.

Farallon Capital Management first reported a position in ROIV in Q2 2023 and has held it in 12 quarters since. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Farallon Capital Management held 9,675,000 shares of Roivant Sciences worth $268M as of Q1 2026.
Farallon Capital Management bought 9,638,000 Roivant Sciences shares in Q1 2026, an estimated $248M.
Roivant Sciences made up 1.53% of Farallon Capital Management's portfolio in Q1 2026, its #23 holding.
Farallon Capital Management first reported a position in Roivant Sciences in Q2 2023 and has held it in 12 quarters since.
439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.